Related Experiment Video
Updated: Jan 22, 2026
10:42
Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
4.2K
Chemotherapy for Esophageal Adenocarcinoma
1Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. lamkaon@hku.hk.
Methods in Molecular Biology (Clifton, N.J.)
|March 31, 2018
Summary
Esophageal adenocarcinoma is distinct from squamous cell carcinoma, requiring tailored chemotherapy. This chapter reviews the best evidence for managing this disease in curative and palliative settings.
Area of Science:
- Gastroenterology
- Oncology
- Medical Research
Background:
- Esophageal and esophagogastric junction adenocarcinoma is a distinct disease entity from esophageal squamous cell carcinoma.
- Despite sharing the same anatomical location, their etiology and biology differ significantly.
- Current treatment guidelines often extrapolate evidence from gastric carcinoma for adenocarcinoma management.
Purpose of the Study:
- To present the best available evidence for chemotherapy management of esophageal adenocarcinoma.
- To address both curative and palliative clinical settings for this distinct disease.
- To highlight the need for specific evidence for adenocarcinoma, rather than relying on gastric carcinoma data.
Main Methods:
- Review of current literature and treatment guidelines.
- Synthesis of evidence for chemotherapy in curative settings.
- Synthesis of evidence for chemotherapy in palliative settings.
Main Results:
- Chemotherapy plays a crucial role in both curative and palliative management.
- Evidence for adenocarcinoma is often derived from gastric cancer studies.
- Specific treatment strategies tailored to esophageal adenocarcinoma are essential.
Conclusions:
- Esophageal adenocarcinoma requires distinct management strategies.
- Chemotherapy is a key component in both curative and palliative care.
- Further research focusing specifically on esophageal adenocarcinoma is warranted.
Related Concept Videos
01:24Esophageal Varices-I: Introduction
1.2K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.2K
01:22Esophageal Perforation-I: Introduction
431
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
431
01:30Esophageal Strictures-I: Introduction
671
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
671
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
707
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
707
01:26Esophageal Strictures-II: Clinical Features and Management
459
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
459
01:28Esophageal Perforation-II: Clinical Manifestations and Management
531
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
531